Mechanistically, MYCN suppresses IFN activity and chemokine expression in NB cells, thus providing a possible explanation for this association,12–16 in line with the emerging notion that ICB therapy seems to be ineffective in patients with high-risk NB, although clinical data remain limited.17 18. Here, IFNA1 is linked to neuroblastoma.